The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Dosing & titration

Titrating on tolerability rather than on the calendar

PO
p.onwukaTL216 May 2025#1

On the subject in the title: Titrating on tolerability rather than on the calendar Working notes rather than a conclusion.

An honest uncertainty about titrating on tolerability rather than a disguised assertion.

I do not know the answer and I have not been able to find one. What I have is the shape of the question, which may be worth more than my guess at the answer.

42 likes 14mo
CC
ch.correiaTL219 Jun 2025#2

The most common practical error is not the schedule at all — it is losing track of which step you are on after a break, and then resuming at the top rather than re-approaching it.

0 likes 13mo
MH
ms_hollowayTL4Mass spectrometrist13 Jul 2025 · edited#3
ch.correia, post #2: The most common practical error is not the schedule at all — it is losing track of which step you are on after a break, and then resuming at the top rather than re-approaching it. Go to post

If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure.

A weak preference rather than a position.

1 like in reply to #2 13mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Restarting after a long gap: what the labelling implies — the long version
Restarting after a long gap: what the labelling implies — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
OFDIBRMHF+12 17 2.4k 2mo
Where the four-week escalation interval comes from, and what it is not
On the subject in the title: Where the four-week escalation interval comes from, and what it is not Working notes rather than a conclusion. Working notes on four-week escalation interval rather than a…
CCNWVNRW+56 60 21k 2y
When a dose reduction is the correct response to a side effect
When a dose reduction is the correct response to a side effect — that is the question, and I have not found it answered plainly anywhere I have looked. I have read the maintained page on this and I still have…
VMSRMJSTD+38 42 2.7k 19h
Revisiting: Holding a dose indefinitely: is there a documented downside?
The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it. I have read the maintained page on this…
MVBVPKCC+26 30 4.5k 18mo
[2026 update] Dose numbers across compounds are not on the same scale
On the subject in the title: Dose numbers across compounds are not on the same scale Working notes rather than a conclusion. A narrow question about Dose numbers across compounds, deliberately narrow, because…
KVBVHDITNL+14 18 1.2k 13mo

Related topics — sharing the tags dose reduction, tirzepatide, worked example

TopicParticipantsRepliesViewsActivity
GLP-1 receptor distribution: central and peripheral
Posting this under the heading it deserves: GLP-1 receptor distribution: central and peripheral Everything below is what sits behind that. I have spent a fortnight trying to pin GLP-1 receptor distribution…
KHBPJNNSNH+90 98 30k 22h
How much of the diluent volume the powder itself displaces
Asking directly, because I could not find a straight answer: How much of the diluent volume the powder itself displaces Writing this out with the numbers in it, because "roughly" is how these go wrong. Vial:…
CCFPHI 2 1.8k 1d
Pre-registering a personal experiment, seriously
Pre-registering a personal experiment, seriously — setting out what I have, and where I think it stops being reliable. A narrow question about pre-registering a personal experiment, deliberately narrow,…
PADAVSSJL+96 119 58k 14mo
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version
Posting this under the heading it deserves: Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Everything below is what sits behind that. I have read the maintained page…
JSSSIBSBSO+138 148 1.8k 2y
The C-cell question: rodent findings and their human context — what changed since
The C-cell question: rodent findings and their human context — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of c-cell question…
TKJEPPSDPN+61 65 1.3k 22mo